-
公开(公告)号:EP4162934B1
公开(公告)日:2024-10-30
申请号:EP22202824.3
申请日:2013-06-14
-
公开(公告)号:EP4431088A1
公开(公告)日:2024-09-18
申请号:EP24382217.8
申请日:2024-02-28
CPC分类号: A61K9/2013 , A61K9/2018 , A61P3/10 , A61P9/04 , A61P13/12 , A61K31/155 , A61K31/70
摘要: The present invention relates to a uniform pharmaceutical composition comprising dapagliflozin, metformin and at least one surfactant. Manufacturing processes of such composition are also described.
-
公开(公告)号:EP3698801B1
公开(公告)日:2024-09-04
申请号:EP18867498.0
申请日:2018-10-19
IPC分类号: A61K31/4985 , A61K31/427 , A61K33/30 , A61K38/43 , A61K31/155 , A61K31/702 , A61K31/4439 , A61K31/70 , A61P3/10
CPC分类号: A61K31/155 , A61K33/30 , A61K38/43 , A61K31/4439 , A61K31/4985 , A61K31/70 , A61P3/10
-
公开(公告)号:EP4419688A2
公开(公告)日:2024-08-28
申请号:EP22884709.1
申请日:2022-10-20
申请人: Prime Medicine, Inc.
发明人: YEH, Wei Hsi
-
公开(公告)号:EP3494975B1
公开(公告)日:2024-07-24
申请号:EP18196347.1
申请日:2007-10-30
IPC分类号: A61K31/70 , A61K31/7068 , A61K31/7088 , C12N15/113
-
公开(公告)号:EP4384186A1
公开(公告)日:2024-06-19
申请号:EP22856658.4
申请日:2022-08-12
发明人: YAN, Jun
IPC分类号: A61K31/716 , A61K36/06 , A61K31/715 , A61K31/70
CPC分类号: A61K31/716 , A61K36/064
-
公开(公告)号:EP4380945A2
公开(公告)日:2024-06-12
申请号:EP22868207.6
申请日:2022-09-13
发明人: KEITZ, Paul , BERGNES, Gus , GALLOP, Mark A. , QUARTA, Marco
-
公开(公告)号:EP4380575A1
公开(公告)日:2024-06-12
申请号:EP22868391.8
申请日:2022-09-13
IPC分类号: A61K31/70 , A61K31/7004 , A61K31/01 , A61K31/702
-
-
公开(公告)号:EP4344547A1
公开(公告)日:2024-04-03
申请号:EP23825351.2
申请日:2023-07-04
发明人: HAN, Seung Hyun , PARK, Dong Hyun , LEE, Dongwook
IPC分类号: A01N63/20 , A01P3/00 , A61K31/70 , A61K35/74 , A61K35/744 , A61P31/10 , C09D5/14 , A23L33/10 , A23K10/16
摘要: The present invention relates to an antifungal composition using lipoteichoic acid derived from various Gram-positive bacteria to inhibit the adhesion and aggregation of Candida fungi, a pharmaceutical composition for preventing and treating candidiasis infection and the use thereof. Using this approach, since the effect of inhibiting adhesion and cohesion, which are the representative virulence factors of Candida fungal infection and candidiasis, has been confirmed, it can be used for antifungal use against Candida fungi and for prevention or treatment related to candidiasis infection.
-
-
-
-
-
-
-
-
-